About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
AstraZeneca Oncology
Ovarian Cancer
Lung Cancer
COVID-19
Immunotherapies
Screening and Detection
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Effective Communication between Radiation and Medical Oncologist May Improve Concurrent CRT in Unresectable Stage III NSCLC
By
AstraZeneca Oncology
FEATURING
Roy Decker
,
Mark Socinski
,
Jhanelle Gray
,
Mary Grizzard
By
AstraZeneca Oncology
FEATURING
Roy Decker
,
Mark Socinski
,
Jhanelle Gray
,
Mary Grizzard
914 views
November 15, 2019
Comments are disabled for this content.
Immunotherapies
06:27
AstraZeneca Oncology
Importance of Proactive AE Management and Patient Education for Conc…
Feat.
R. Decker,
J. Gray,
J. Chang,
V. Sherry,
V. Villaflor,
M. Socinski,
K. Higgins
06:01
AstraZeneca Oncology
Advances in Radiation Technology May Improve Concurrent CRT in Unres…
Feat.
R. Decker,
M. Socinski,
J. Chang,
K. Higgins
04:40
AstraZeneca Oncology
Even Patients With Locally Advanced Stage III NSCLC May Be Treated W…
Feat.
R. Decker,
J. Gray,
J. Chang,
M. Socinski,
K. Higgins
03:43
AstraZeneca Oncology
Effective Communication between Radiation and Medical Oncologist May…
Feat.
R. Decker,
M. Socinski,
J. Gray,
M. Grizzard